Norwegian startup ClexBio is bioengineering human veins to implant inside a patient’s body. Together with CSEM, a Swiss R&D centre, the company has built a prototype bioreactor to grow the veins.

Optical phantoms and tissue-mimicking materials have emerged as essential tools in the validation, calibration and optimisation of biomedical imaging systems. By replicating the optical and sometimes ...

A team led by the Institute for Bioengineering of Catalonia (IBEC) and the Hospital del Mar Research Institute has developed ...

Miami University’s Biomedical Engineering and Biotechnology research cluster leverages interdisciplinary collaboration to solve critical health and clinical challenges. Research spans from tissue ...

Neural tissue engineering aims to mimic the brain's complex environment, the extracellular matrix, which supports nerve cell growth, development, and proper connectivity. This environment is carefully ...

Corneal transplantation using donor tissue is currently the primary treatment for corneal endothelial insufficiency. Despite the potential for vision restoration through corneal transplantation, there ...

DURHAM – Humacyte has secured up to $150 million in new capital – including $40 million upfront – from Oberland Capital Management as the firm moves to commercialize bioengineered human tissue.

Nanoscale structure-property relationships of biological materials, genetic and molecular origins of soft joint tissue diseases, biomaterials under extreme conditions, coupling between ...

Emily Miller is a fifth year Biomedical Engineering (BME) PhD student conducting research in Dr. Corey Neu's Soft Tissue Bioengineering Lab. She will defend her dissertation in summer 2024. What ...

A new biomaterial that can be injected intravenously, reduces inflammation in tissue and promotes cell and tissue repair. The biomaterial was tested and proven effective in treating tissue damage ...

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global actuarial consulting, risk management, and technology firm, today released its 2025 report on U.S. organ and tissue transplant costs and ...